The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia
Clinical trial NCT04273529 · UNKNOWN
Trial details
- NCT number
- NCT04273529
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2020-05-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.